Recovery And Migration Of Application Logic From Legacy Systems

Future Internet technologies necessitate dramatic changes in system design, deliveryand usage patterns. For many legacy applications it means that their furtherdevelopment and transition to the Internet becomes problematic or evenimpossible due to the obsolescence of technologies they use. Replacement ofthe old system with the new one, built from scratch, is usually economicallyunacceptable. Therefore, there is a call for methods and tools supportingthe automated migration of legacy systems into a new paradigm. This paperproposes a tool supported method for recovery and migration of applicationlogic information from legacy systems. The information extracted from a legacyapplication is stored in the form of precise requirement-level models enablingautomated transformation into a new system structure in a model-driven way.Evaluation of the approach is based on a case study legacy system

La estirpe de Pigmalión: poesía y escultura en el Siglo de Oro

Ni Venus ni Pigmalión sabían bien la que estaban armando cuando entre los dos dieron vida a la estatua de una mujer más hermosa que ninguna, historia canonizada por las Metamorfosis de Ovidio. Y es que el «efecto Pigmalión» examinado por Stoichita (2008) es el mito fundador del simulacro y repercute en toda la historia de la representación, porque la estatua procede de la imaginación del artista sin modelo alguno y la animación procede únicamente del «pouvoir des mots, et des mots seuls». Así, el mito de Pigmalión gana una gran potencia significativa como emblema artístico, ya que canoniza a la par el poder del arte y la fuerza de la palabra

Version 1.00

Distribution Publi

Version 1.00 Status Final

Distribution Publi

Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

Aims We aimed to evaluate the association between metabolic syndrome (MetS) and long-term all-cause mortality. Methods The LIPIDOGRAM studies were carried out in the primary care in Poland in 2004, 2006 and 2015. MetS was diagnosed based on the National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III) and Joint Interim Statement (JIS) criteria. The cohort was divided into four groups: non-obese patients without MetS, obese patients without MetS, non-obese patients with MetS and obese patients with MetS. Differences in all-cause mortality was analyzed using Kaplan-Meier and Cox regression analyses. Results 45,615 participants were enrolled (mean age 56.3, standard deviation: 11.8 years; 61.7% female). MetS was diagnosed in 14,202 (31%) by NCEP/ATP III criteria, and 17,216 (37.7%) by JIS criteria. Follow-up was available for 44,620 (97.8%, median duration 15.3 years) patients. MetS was associated with increased mortality risk among the obese (hazard ratio, HR: 1.88 [95% CI, 1.79-1.99] and HR: 1.93 [95% CI 1.82-2.04], according to NCEP/ATP III and JIS criteria, respectively) and non-obese individuals (HR: 2.11 [95% CI 1.85-2.40] and 1.7 [95% CI, 1.56-1.85] according to NCEP/ATP III and JIS criteria respectively). Obese patients without MetS had a higher mortality risk than non-obese patients without MetS (HR: 1.16 [95% CI 1.10-1.23] and HR: 1.22 [95%CI 1.15-1.30], respectively in subgroups with NCEP/ATP III and JIS criteria applied). Conclusions MetS is associated with increased all-cause mortality risk in non-obese and obese patients. In patients without MetS obesity remains significantly associated with mortality. The concept of metabolically healthy obesity should be revised